跳至主要内容
临床试验/JPRN-UMIN000002671
JPRN-UMIN000002671已完成未知

A study of therapeutic angiogenesis in critical limb ischemia using gelatin hydrogel incorporating basic fibroblast growth factor - Therapeutic angiogenesis by basic fibroblast growth factor

Kyoto University Graduate School of Medicine Department of Cardiovascular Surgery0 个研究点目标入组 10 人开始时间: 2009年10月26日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Hemodialysis Active diabetic retinopathy Active malignancy Current smoker Allergy for gelatin

研究者

发起方
Kyoto University Graduate School of Medicine Department of Cardiovascular Surgery

相似试验

已完成
1 期
Clinical Study of Therapeutic Angiogenesis Using Hypoxic Preconditioned Peripheral Blood Mononuclear CellsPeripheral arterial occlusive disease
JPRN-UMIN000018594Yamaguchi University Graduate School of Medicine Department of Surgery and Clinical Science7
已完成
1 期
A clinical trial to evaluate the effect of bone marrow derived stem cell in diseases Limb Ischemia
CTRI/2010/091/000565Department of Biotechnology New Delhi80
未知
不适用
Multicenter trial of therapeutic angiogenesis in patients with intractable vasculitis
JPRN-UMIN000000939Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine40
招募中
不适用
A new treatment for skin ulcers associated with systemic sclerosis using the ability of own bone marrow cells to regenerate blood vesselsSystemic sclerosis, Vasculopathy, Skin ulcer, Raynaud's phenomenonSystemic sclerosis
JPRN-jRCTb032210204Yoshimi Ryusuke12
进行中(未招募)
不适用
Effect of angiogenesis inhibiting therapy in patients progressing on endocrine treatment and patients with triple negative breast cancer - a translational phase II study within theSwedish Association of Breast Oncologists SABO-2010-01Patients with breast cancer who are oestrogen receptor positive but HER2 negative and progressing on endocrine therapy. Patients with locally advanced or recurrent triple negative breast cancer (TNBC) can also be included. Patients with TNBC will not receive endocrine therapy.MedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-022065-10-SESahlgrenska University Hospital